EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle‐Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA ‐ MIBC Study

Eiji Kikuchi iD, Jumpei Tokumaru iD, Daisuke Kawai, Ryotaro Ide iD, Hiroshi Komazaki iD, Hiroshi Kitagawa iD, Junichi Inokuchi iD

International Journal of Urology · 2026-07 · 33 (7)

DOI: 10.1111/iju.70565 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Urology, online erschienen am 25.07.2026. Verfasst von Eiji Kikuchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Neoadjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca K.K..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To characterize the temporal changes in perioperative systemic treatment patterns and postoperative mortality among Japanese patients with stage II–III muscle‐invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) from 2013 to 2024.

Methods

This retrospective observational cohort study assessed neoadjuvant chemotherapy (NAC) and adjuvant therapy (AT) relative to RC. Treatment patterns (NAC + RC + AT, NAC + RC, RC + AT, and RC alone), NAC regimen selection, and 30‐ and 90‐day postoperative mortality were evaluated across three periods (2013–2017, 2018–2021, and 2022–2024). Analyses were descriptive.

Results

Among 5 208 patients, the use of NAC + RC increased from 31.4% in 2013–2017 to 50.4% in 2022–2024, and the use of NAC + RC + AT increased from 8.7% to 22.4%. RC alone decreased from 46.3% to 21.4%. Reduced‐dose gemcitabine + cisplatin (GC) and gemcitabine + carboplatin were frequently used and remained common throughout the study period. In 2022–2024, 18.8% of patients received adjuvant nivolumab; most had received NAC beforehand (242/270). The 30‐ and 90‐day mortality remained low regardless of the increase in NAC use (30‐day: ≤ 0.2% with NAC vs. ≤ 1.5% without; 90‐day: ≤ 1.4% with NAC vs. ≤ 3.3% without).

Conclusions

Perioperative systemic therapy for MIBC in Japan has intensified over the past decade, with increased adoption of NAC and adjuvant nivolumab. Dose‐modified GC and carboplatin‐based regimens have remained commonly used throughout the study period. Even with increased NAC use, postoperative mortality has remained low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsHumansJapanFemaleRetrospective StudiesMaleAgedChemotherapy, AdjuvantNeoplasm InvasivenessMiddle AgedNeoplasm StagingDeoxycytidineGemcitabineCisplatin

Stichwörter der Autor:innen

cystectomydatabaseneoadjuvant therapyretrospective studiesurinary bladder neoplasms

Substanzen

DeoxycytidineGemcitabineCisplatin

Autor:innen und Institutionen

  • Department of Urology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
  • Medical Department, Astra Zeneca K.K., Tokyo, Japan.
  • Department of Urology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

ORCID-Profile: Eiji Kikuchi, Jumpei Tokumaru, Ryotaro Ide, Hiroshi Komazaki, Hiroshi Kitagawa, Junichi Inokuchi

Förderung

  • AstraZeneca K.K.

Zitieren

APA

Kikuchi, E., Tokumaru, J., Kawai, D., Ide, R., Komazaki, H., Kitagawa, H., & Inokuchi, J. (2026). Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle‐Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA ‐ MIBC Study. International Journal of Urology, 33(7). https://doi.org/10.1111/iju.70565

Vancouver

Kikuchi E, Tokumaru J, Kawai D, Ide R, Komazaki H, Kitagawa H, et al. Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle‐Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA ‐ MIBC Study. International Journal of Urology. 2026;33(7). doi:10.1111/iju.70565

BibTeX
@article{Kikuchi2026,
  author = {Kikuchi, Eiji and Tokumaru, Jumpei and Kawai, Daisuke and Ide, Ryotaro and Komazaki, Hiroshi and Kitagawa, Hiroshi and Inokuchi, Junichi},
  title = {Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle‐Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA ‐ MIBC Study},
  journal = {International Journal of Urology},
  year = {2026},
  volume = {33},
  number = {7},
  doi = {10.1111/iju.70565}
}
Kostenlos starten →